This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Prostate Cancer
  • /
  • PSA response to cabazitaxel is associated with imp...

PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study.

Read time: 1 mins
Published:5th Jan 2018
Author: Hammerer P, Al-Batran SE, Windemuth-Kieselbach C, Keller M, Hofheinz RD.
Availability: Pay for access, or by subscription
Ref.:World J Urol. 2018.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest